Skip to content

EFFECT OF â??SAPTAMRITA VATIâ?? AND â??VIRECHANA KARMAâ?? IN TAMAKA SHWASA WITH SPECIAL REFERENCE TO BRONCHIAL ASTHMA

CLINICAL EVALUATION OF â??SAPTAMRITA VATIâ?? AND â??VIRECHANA KARMAâ?? IN THE MANAGEMENT OF TAMAKA SHWASA W.S.R. TO BRONCHIAL ASTHMA

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/033056
Enrollment
30
Registered
2021-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J452- Mild intermittent asthma

Interventions

Intervention1: Saptamrita Vati: â?? 15 patients will be administered Saptamrita Vati in dose of 5gm twice a day orally empty stomach for 30 days with Anupana of Luke warm water. Intervention2: saptam

Sponsors

National Institute of Ayurveda Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing for trial and give consent. 2. Patients of age group 18 to 70 yrs of either sex. 3. Patients having signs and symptoms of Tamak Shwasa i.e., Shwasakrucchata, Kasa (cough), Pratishyaya (chronic rhinitis), Bhasankrucchata (difficulty in speech), Nidralpata (inadequate sleep), Ghurghuraka (audible sounds) 4. Patients fit for Virechana Karma. 5. Patients who is not taking any allopathic medication for Asthma. 6. Mild & moderate cases of Bronchial Asthma

Exclusion criteria

Exclusion criteria: 1. Patients not willing for trial. 2. Age below 18 years and above 70 years of age of either sex. 3. Patients suffering from Pulmonary tuberculosis, Cardiac Asthma, Bronchogenic carcinoma, Chronic obstructive Productive disease, Pleural effusion 4. Status Asthmaticus 5. Patients suffering from serious heart diseases or any other serious health aliment. 6. Patient with rectal or vaginal prolapse 7. Pregnant and lactating women 8. Patients, who are unfit for Virechana Karma 9 Patients, who is taking any allopathic medication for Asthma

Design outcomes

Primary

MeasureTime frame
Improvement in clinical Symptoms of Tamaka ShwasaTimepoint: 30 days

Secondary

MeasureTime frame
1.Changes in Asthma control questionnaire 2. Changes in Spirometry- FVC1% and PEFR 3. Changes in MRC Dyospnea Scale. Timepoint: 30 DAYS

Countries

India

Contacts

Public ContactDr Abhishek Upadhyay

National Institute of Ayurveda Jaipur

joshirk1964@gmail.com9414322297

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026